Aurobindo Pharma

Pharma earnings to reflect full COVID-19 impact in Apr-Jun quarter; 4 pharma stocks to gain up to 16%

Pharmaceutical sector will reflect the full impact of COVID-19 restrictions on the back of pre-buying in chronic therapies in March quarter, underperformance in the acute segment due to delays in elective surgeries and shut-d

Sun Pharma, Aurobindo Pharma among top stock picks from Pharma sector; CLSA sees gain up to 30%

Among pharma stocks, the top stock picks of CLSA are Sun Pharma, Cipla, Aurobindo Pharma and Cadila Healthcare, recommending a 'buy' rating on them

Aurobindo Pharma shares drop 18% as USFDA revokes VAI status for Unit IV; brokerages revise target price

Aurobindo Pharma in a BSE filing said it has received a communication that US FDA inspection at Unit IV is still open and under review.

Aurobindo Pharma shares gain over 4% as Q4 net profit climbs 39%

Aurobindo Pharma shares advanced as much as 4.32 per cent on Tuesday after the company posted a jump of 39.39 per cent in its consolidated net profit figures at Rs 562.85 crore for the quarter ended March 31, 2016

aurobindo pharma, bse sensex

Aurobindo Pharma Q4 net profit at Rs 563 crore

Drug maker Aurobindo Pharma today posted a consolidated net profit at Rs 562.85 crore for the fourth quarter ended March 31.

aurobindo pharma, bse sensex

Aurobindo Pharma gets US FDA nod for anaesthetic injection

The product is expected to be launched in the second quarter of 2016-17 fiscal, it added

Aurobindo Pharma gets USFDA nod for anaesthetic injection

Aurobindo Pharma has received final nod from the US health regulator to manufacture and market its anaesthetic Bupivacaine Hydrochloride injection in the American market.

Aurobindo pharma, Bupivacaine Hydrochloride injection, USFDA, BSE, ANDA, Hospira Incorporation, Marcaine, Aurolife Pharma,

Aurobindo Pharma gets USFDA nod for generic migraine drug

Aurobindo Pharma has received approval from the US health regulator to sell generic Zolmitriptan tablets, a drug used to treat migraine, in the American market.

Aurobindo Pharma

Aurobindo Pharma gets final USFDA nod for cholesterol drug

Aurobindo Pharma has received final approval from the USFDA to manufacture and market Fenofibrate tablets, used for the treatment of high level of cholesterol, in the American market.

aurobindo

Aurobindo Pharma shares surge on USFDA approval for epilepsy drug

Aurobindo Pharma shares advanced over 4 per cent on Tuesday after the pharma company announced that it has received USFDA approval for its epilepsy prevention drug Lacosamide

zydus

Maruti Suzuki, HCL Tech, Yes Bank among 8 stocks that trended in Thursday’s trade

Maruti Suzuki shares closed 2.94 per cent down at Rs 3748.45 after Japense yen soared almost 3 per cent against the dollar and euro as the Bank of Japan opted out of any further moves to ease policy.

BSE Sensex, NSE nifty

Aurobindo Pharma gets USFDA nod for blood pressure drug

Aurobindo Pharma today said it has received final approval from the US health regulator to manufacture and market generic version of blood pressure treatment drugs Amlodipine and Valsartan tablets

Aurobindo Pharma gets US FDA nod for valganciclovir tabs

Valganciclovir tablets is an anti-viral used in the treatment of Cytomegalovirus (CMV) retinitis Aurobindo Pharma received final approval from the US Food & Drug Administration (US FDA) to manufacture and market valgancic

Aurobindo Pharma receives US FDA approval for rivastigmine tartrate capsules

The product is expected to be launched in Q1 FY16-17

Aurobindo Pharma shares gain on USFDA nod for osteoporosis drug

Aurobindo Pharma shares gained over 3 per cent on Monday after it announced that the company has received final approval from USFDA to manufacture and market Naproxen Sodium Tablets

aurobindo pharma, bse sensex

15 stocks that trended in Monday’s trade: VA Tech Wabag, Persistent Systems and more

VA Tech Wabag stocks settled 4.85 per cent up at Rs 533.20 after the company informed stock exchanges that it has bagged record orders worth Rs 5,000 crore in FY 2016.

Stocks in focus today

Aurobindo Pharma receives US FDA approval for Acetylcysteine injection

The product is likely to be launched in Q1 FY16-17

Aurobindo Pharma gets USFDA nod for fungal infections tablets

The company has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Voriconazole tablets in the strengths of 50 mg and 200 mg, Aurobindo Pharma said in a statement.

natco pharma

Aurobindo Pharma gets USFDA nod for generic Tranexamic acid injection

Aurobindo Pharma has received final approval from the USFDA to manufacture and market its Tranexamic acid injection, used for treating hemophilia, in the American market. The company plans to launch the product by the end of

Aurobindo Pharma gets US FDA approval for norethindrone acetate tabs

The tablets are used in the treatment of endometriosis, uterine bleeding caused by abnormal hormone levels, and secondary amenorrhea Aurobindo Pharma has received the final approval from the US Food & Drug Administration

Aurobindo pharma to build pharmaceutical factory in Saudi Arabia

Indian manufacturer Aurobindo has become the latest global conglomerate to launch its factory in Saudi Arabia.

Aurobindo Pharma gets shareholders’ nod to raise up to $600 million

The funds will facilitate and meet the additional capital expenditure requirements for the ongoing and future projects of the company Aurobindo Pharma has received shareholders’ nod to raise up to $600 million (around R

Aurobindo Pharma receives US FDA approval for allergic conjunctivitis solution

The approved product has an estimated market size of $235 million

Aurobindo Pharma gets USFDA nod for its conjunctivitis drug

The company has received final approval from the United States Food & Drug Administration (USFDA) to manufacture and market Olopatadine Hydrochloride Ophthalmic Solution USP in the strength of 0.1 per cent

Aurobindo Pharma receives USFDA approval for methylprednisolone sodium succinate injection

The approved product has an estimated market size of $102 million for the twelve months ending October 2015 according to IMS Aurobindo Pharma has received final approval from the US Food & Drug Administration (US FDA) to

Aurobindo Pharma shares gain on USFDA approval for diarrhoea, allergy drugs

At 1:39 pm, the shares of Aurobindo Pharma were trading 1.76 per cent up at Rs 834.75 on BSE, while on NSE, the scrip gained 1.68 per cent at Rs 834.25. Sensex was up 0.14 per cent at 25,530.96.

aurobindo

Sensex, Nifty to make flat-to-cautious start on GST woes; Aurobindo Pharma, Biocon in focus today

The BSE Sensex and NSE Nifty are likely to open on a soft-to-cautious note on Thursday tracking SGX Nifty

sks microfinance share price, Sensex, NIfty, BSE, NSE
Advertisement
Income Tax Calculator, Budget 2019, How to Calculate Income Tax

 

Stock Market

Most Read

Advertisement

Budget 2020

Advertisement

Related Articles